IMP: SSC approved the result of the share issuance

SSC approved the result of the share issuance of Imexpharm Corporation as follows:

HOSE

>   NLG: Stock issuance under ESOP (31/10/2023)

>   BID: Plan for increasing charter capital (30/10/2023)

>   VIC: Information related to the international bond issuance (30/10/2023)

>   REE: Completing the additional capital contribution at REE Energy (30/10/2023)

>   VPB: SSC approved the results of share issuance (26/10/2023)

>   VIC: Plan for the share issuance under ESOP (26/10/2023)

>   VHC: Notice of stock issuance for the ESOP (26/10/2023)

>   PDR: SSC received the dossier of the share issuance (26/10/2023)

>   VJC: Clarification of interest terms in the bond issuance plans (26/10/2023)

>   DXG: BOD resolution on stock issuance under ESOP (26/10/2023)